S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Cerence (CRNC) Earnings Date, Estimates & Call Transcripts

$11.26
-0.85 (-7.02%)
(As of 04:00 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 6)
$0.95 Beat By $0.23
Consensus EPS
(Feb. 6)
$0.72
Skip Charts & View Estimated and Actual Earnings Data

CRNC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRNC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cerence Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q2 20241($0.43)($0.43)($0.43) 
Q3 20241$0.10$0.10$0.10 
Q4 20241$0.14$0.14$0.14 
20243($0.19)($0.19)($0.19) 
Q1 20251$0.09$0.09$0.09 
Q2 20251$0.08$0.08$0.08 
Q3 20251$0.09$0.09$0.09 
Q4 20251$0.15$0.15$0.15 
FY 20254$0.41$0.41 $0.41

CRNC Earnings Date and Information

Cerence last posted its earnings data on February 6th, 2024. The reported $0.95 EPS for the quarter, topping the consensus estimate of $0.72 by $0.23. The business earned $138.34 million during the quarter, compared to analyst estimates of $130.89 million. Cerence has generated ($0.82) earnings per share over the last year (($0.82) diluted earnings per share). Earnings for Cerence are expected to decrease by -92.59% in the coming year, from $0.54 to $0.04 per share. Cerence has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Cerence Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
2/6/2024Q1 2024$0.72$0.95+$0.23$1.37$130.89 million$138.34 million
11/27/2023Q3 2023$0.15$0.09($0.06)$0.03$74.37 million$80.80 million    
8/8/2023Q3 2023($0.34)($0.22)+$0.12($0.03)$60.83 million$61.66 million
5/9/2023Q2 2023($0.38)($0.35)+$0.03($0.05)$66.33 million$68.39 million
2/8/2023Q1 2023($0.03)$0.10+$0.13$0.25$76.97 million$83.66 million
11/29/2022Q4 2022($0.39)($0.27)+$0.12$5.30$55.05 million$58.14 million
8/9/2022Q3 2022$0.29$0.27($0.02)$3.07$91.73 million$89.00 million    
5/10/2022Q2 2022$0.20$0.11($0.09)$0.23$84.59 million$86.30 million    
2/7/2022Q1 2022$0.31$0.57+$0.26$0.67$95.10 million$94.40 million    
11/22/2021Q3 2021$0.57$0.66+$0.09$0.44$97.92 million$98.10 million    
8/8/2021Q2 2021$0.54$0.62+$0.08$0.49$95.96 million$96.80 million    
5/9/2021Q1 2021$0.52$0.69+$0.17$0.58$94.00 million$98.70 million  

Cerence Earnings - Frequently Asked Questions

When is Cerence's earnings date?

Cerence has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on CRNC's earnings history.

Did Cerence beat their earnings estimates last quarter?

In the previous quarter, Cerence (NASDAQ:CRNC) reported $0.95 earnings per share (EPS) to beat the analysts' consensus estimate of $0.72 by $0.23. Learn more on analysts' earnings estimate vs. CRNC's actual earnings.

How much revenue does Cerence generate each year?

Cerence (NASDAQ:CRNC) has a recorded annual revenue of $294.48 million.

How much profit does Cerence generate each year?

Cerence (NASDAQ:CRNC) has a recorded net income of -$56.25 million. CRNC has generated -$0.82 earnings per share over the last four quarters.

What is Cerence's EPS forecast for next year?

Cerence's earnings are expected to decrease from $0.54 per share to $0.04 per share in the next year, which is a -92.59% change.


More Earnings Resources from MarketBeat

This page (NASDAQ:CRNC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners